Study of Stress Hyperglycemia as an Indicator of Diabetes Mellitus

Yale University

Status: Terminated

Conditions: Diabetes Mellitus Type 2; Stress Hyperglycemia

Study type: Observational

Funder types: Other

Identifiers

NCT02068989

1301011408

Details and patient eligibility

About

We hypothesize that stress hyperglycemia is an indicator that a patient will develop type 2 diabetes mellitus in the future. Subjects who are not diabetic are enrolled and blood glucose readings reviewed during their intensive care unit stay. All subjects are consented and have a HbA1C level drawn to determine if they have diabetes mellitus or not. They are then followed up in 1 year and the HbA1C repeated to determine if they have developed diabetes mellitus over the course.

Enrollment: 1 patient

Sex: All

Ages: 18 to 80 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• All patients admitted to the intensive care unit at the Yale New Haven Hospital St. Raphael Campus and Norwalk Hospital

Exclusion criteria

• Patients with prior history of diabetes mellitus
• Elevated admission HbA1c (≥6.5%)
• Age >80 years
• Metastatic disease with expected life expectancy of less than 12 months
• Pregnancy or a woman who plans to become pregnant

Trial design

1 participants in 2 patient groups

Stress Hyperglycemic Group

Description:

Repeat HbA1C in 1 year

Euglycemic Group

Description:

Repeat HbA1C in 1 year